Friday 6 November 2026 Export PTCT’s income statement to Excel — free account

PTC Therapeutics, Inc.

PTC Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.7 billion, up 114.5% from fiscal 2024.

Revenue: +69.6%
EPS: −409.7%
Free cash flow: +90.3%
Total debt: +19.3%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

65.55 0.12 −0.18%

Follow PTCT

Alert me

Market cap: $5.5B
P/E: 0.0×
Fwd P/E: 42.2×
Dividend yield: —
F-score: 7/9
Altman Z: 1.86
Beneish M: −1.48
Dividend safety: n/a

Overview

PTC Therapeutics, Inc. (PTCT) Current ratio

Alert me on Current ratio

PTC Therapeutics, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.3×, up 0.9× from fiscal 2025 (2.3×). Over the past ten years it has ranged from 1.7× (fiscal 2022) to 7.8× (fiscal 2015); the current reading is higher than 45% of that period. That is below the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/PTCT/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="PTC Therapeutics, Inc. current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/PTCT/metrics/current-ratio">PTC Therapeutics, Inc. (PTCT) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	2.3×	(0.10%)
FY2024	2.4×	16.32%
FY2023	2.0×	18.32%
FY2022	1.7×	(8.85%)
FY2021	1.9×	(57.81%)
FY2020	4.4×	34.42%
FY2019	3.3×	71.77%
FY2018	1.9×	(36.63%)
FY2017	3.0×	(42.35%)
FY2016	5.3×	(32.86%)

Period	Current ratio	Change
Sep 2026	3.3×	(3.67%)
Jun 2026	3.4×	39.10%
Mar 2026	2.4×	3.93%
Dec 2025	2.3×	1.31%
43 more quarters	Free account

Against its own ten years

Low 1.7× High 7.8×

Ten-year median 2.4×

Current reading's percentile 45

Company	Current ratio
MANE Veradermics Incorporated compare	70.5×
BLTE Belite Bio, Inc. Sponsored ADR compare	33.6×
CGON CG Oncology, Inc. compare	22.2×
COGT Cogent Biosciences, Inc. compare	13.6×
IMVT Immunovant, Inc. compare	7.3×
SRRK Scholar Rock Holding Corporation compare	7.0×
PTCT PTC Therapeutics, Inc.	3.3×
KOD Kodiak Sciences Inc. compare	2.5×
MIRM Mirum Pharmaceuticals, Inc. compare	2.1×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

PTC Therapeutics, Inc. (PTCT) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on PTCT

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on PTCT

Stockrow Weekly